Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
December 8, 2025Blood

Regional, and hospital-level disparities in mortality and ICU-level care among hospitalized peripheral T-cell lymphoma patients: Insights from the 2022 national inpatient sample

View Full Paper
Ask AI
Bookmark
Share

Authors

YCYoon‐Hee ChoiIPIn-Ae Park

Discussion

Loading...

Member takes

Overview

Observational study reveals higher mortality rates in Medicaid patients and regional disparities in peripheral T-cell lymphoma care.

Key Points

  • To evaluate disparities in mortality and ICU-level care for hospitalized peripheral T-cell lymphoma patients based on insurance status and regional factors.
  • Analyzed hospitalizations for peripheral T-cell lymphoma using 2022 National Inpatient Sample
  • Utilized ICD-10-CM codes for disease categorization
  • Examined relationships between mortality, ICU care, hospital characteristics, and insurance status
  • Identified 8,865 hospitalizations for peripheral T-cell lymphoma in 2022
  • In-hospital mortality rate was 8% overall, with significant variation by subtype
  • Medicaid patients faced a mortality rate of ~10%, nearly double that of privately insured patients (~5%)
  • ICU-level care was necessary for ~10% of admissions, varying by insurance type
  • Regions such as the South had higher inter-hospital transfer rates compared to the Northeast.

Cite This Study

Choi et al. (2025) studied this question.

synapsesocial.com/papers/693624dd4fa91c937236d1bchttps://doi.org/10.1182/blood-2025-8028
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Peripheral T-cell lymphomas: Real-world insights into clinical features and prognosis2025 · 1 citations
  2. 2Facility-level disparities in outcomes of subcutaneous panniculitis-like T-cell lymphoma: A national cancer database analysis2025
  3. 3Association of survival benefit with treatment at academic cancer programs in older adults with PTCL: A National Cancer Database analysis.2026
  4. 4Abstract A007: Treatment setting, socio-demographic factors, and survival of patients with mature lymphoid malignancies (MLM)2025
  5. 5Racial and socioeconomic disparities in clinical trial participation and outcomes in systemic peripheral T-cell lymphoma (PTCL): A multicenter retrospective Study2025 · 1 citations